Inventor
Greer M. Murphy
Inventor
Stanford, CA, US
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Qprimary
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms57%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations43%
PatentTitleYear
8,178,299'Method to determine the risk for side effects of an SSRI treatment in a person'20127,951,538'Method to determine the risk for side effects of an SSRI treatment in a person'20117,083,921'Method to determine the risk for side effects of an SSRI treatment in a person'20066,399,310'Methods for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4'2002Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2002Patents assigned to AKZO NOBEL NV (1)· patent assignee history
2002–2012Based in Stanford, CA, US· patent location history
2006–2012Patents assigned to UNIV LELAND STANFORD JUNIOR (3)· patent assignee history
2012Patents assigned to MURPHY GREER M (1)· patent assignee history
2012Patents assigned to SCHATZBERG ALAN F (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV LELAND STANFORD JUNIOR | 3 | 2006–2012 |
| AKZO NOBEL NV | 1 | 2002 |
| MURPHY GREER Mself | 1 | 2012 |
| SCHATZBERG ALAN F | 1 | 2012 |
Locations
| Location | Patents | Span |
|---|---|---|
| Stanford, California, US | 4 | 2002–2012 |